188 related articles for article (PubMed ID: 23393594)
1. Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.
Sun YL; Chen JJ; Kumar P; Chen K; Sodani K; Patel A; Chen YL; Chen SD; Jiang WQ; Chen ZS
PLoS One; 2013; 8(2):e55576. PubMed ID: 23393594
[TBL] [Abstract][Full Text] [Related]
2. Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).
Shen T; Kuang YH; Ashby CR; Lei Y; Chen A; Zhou Y; Chen X; Tiwari AK; Hopper-Borge E; Ouyang J; Chen ZS
PLoS One; 2009 Oct; 4(10):e7520. PubMed ID: 19841739
[TBL] [Abstract][Full Text] [Related]
3. Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10).
Deng W; Dai CL; Chen JJ; Kathawala RJ; Sun YL; Chen HF; Fu LW; Chen ZS
Oncol Rep; 2013 Jun; 29(6):2479-85. PubMed ID: 23525656
[TBL] [Abstract][Full Text] [Related]
4. PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR.
Anreddy N; Patel A; Sodani K; Kathawala RJ; Chen EP; Wurpel JN; Chen ZS
Acta Pharm Sin B; 2014 Jun; 4(3):202-7. PubMed ID: 26579384
[TBL] [Abstract][Full Text] [Related]
5. bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10).
Chen JJ; Patel A; Sodani K; Xiao ZJ; Tiwari AK; Zhang DM; Li YJ; Yang DH; Ye WC; Chen SD; Chen ZS
PLoS One; 2013; 8(9):e74573. PubMed ID: 24069321
[TBL] [Abstract][Full Text] [Related]
6. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance.
Zhou Y; Hopper-Borge E; Shen T; Huang XC; Shi Z; Kuang YH; Furukawa T; Akiyama S; Peng XX; Ashby CR; Chen X; Kruh GD; Chen ZS
Biochem Pharmacol; 2009 Mar; 77(6):993-1001. PubMed ID: 19150344
[TBL] [Abstract][Full Text] [Related]
7. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance.
Kuang YH; Shen T; Chen X; Sodani K; Hopper-Borge E; Tiwari AK; Lee JW; Fu LW; Chen ZS
Biochem Pharmacol; 2010 Jan; 79(2):154-61. PubMed ID: 19720054
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of anticancer drug sensitivity in multidrug resistance cells overexpressing ATP-binding cassette (ABC) transporter ABCC10 by CP55, a synthetic derivative of 5-cyano-6-phenylpyrimidin.
Wang JQ; Wang B; Ma LY; Shi Z; Liu HM; Liu Z; Chen ZS
Exp Cell Res; 2021 Aug; 405(2):112728. PubMed ID: 34246653
[TBL] [Abstract][Full Text] [Related]
9. CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10).
Wang JQ; Wang B; Teng QX; Lei ZN; Li YD; Shi Z; Ma LY; Liu HM; Liu Z; Chen ZS
Biochem Pharmacol; 2021 Aug; 190():114652. PubMed ID: 34126072
[TBL] [Abstract][Full Text] [Related]
10. PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter.
Chen JJ; Sun YL; Tiwari AK; Xiao ZJ; Sodani K; Yang DH; Vispute SG; Jiang WQ; Chen SD; Chen ZS
Cancer Sci; 2012 Aug; 103(8):1531-7. PubMed ID: 22578167
[TBL] [Abstract][Full Text] [Related]
11. Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.
Sun YL; Kumar P; Sodani K; Patel A; Pan Y; Baer MR; Chen ZS; Jiang WQ
Oncol Rep; 2014 Apr; 31(4):1605-12. PubMed ID: 24481648
[TBL] [Abstract][Full Text] [Related]
12. Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.
Kathawala RJ; Sodani K; Chen K; Patel A; Abuznait AH; Anreddy N; Sun YL; Kaddoumi A; Ashby CR; Chen ZS
Mol Cancer Ther; 2014 Mar; 13(3):714-23. PubMed ID: 24431074
[TBL] [Abstract][Full Text] [Related]
13. Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.
Hopper-Borge E; Xu X; Shen T; Shi Z; Chen ZS; Kruh GD
Cancer Res; 2009 Jan; 69(1):178-84. PubMed ID: 19118001
[TBL] [Abstract][Full Text] [Related]
14. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.
Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R
Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471
[TBL] [Abstract][Full Text] [Related]
15. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).
Chen ZS; Hopper-Borge E; Belinsky MG; Shchaveleva I; Kotova E; Kruh GD
Mol Pharmacol; 2003 Feb; 63(2):351-8. PubMed ID: 12527806
[TBL] [Abstract][Full Text] [Related]
17. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives.
Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK
Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel.
Hopper-Borge E; Chen ZS; Shchaveleva I; Belinsky MG; Kruh GD
Cancer Res; 2004 Jul; 64(14):4927-30. PubMed ID: 15256465
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes.
Patel NR; Rathi A; Mongayt D; Torchilin VP
Int J Pharm; 2011 Sep; 416(1):296-9. PubMed ID: 21703341
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.
Hopper-Borge EA; Churchill T; Paulose C; Nicolas E; Jacobs JD; Ngo O; Kuang Y; Grinberg A; Westphal H; Chen ZS; Klein-Szanto AJ; Belinsky MG; Kruh GD
Cancer Res; 2011 May; 71(10):3649-57. PubMed ID: 21576088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
